Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) in predicting Chemoradiation Sensitive Nasopharyngeal Carcinoma and Plasma Epstein-Barr virus (EBV) level

Not Applicable

• Conditions: asopharyngeal carcinoma; Dynamic contrast enhanced magnetic resonance imaging; Perfusion; Nasopharyngeal carcinoma

• Registration Number: TCTR20180227002
• Lead Sponsor: none

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-02-27
• Study Completion: 2019-02-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Newly diagnosed patients with pathologically proven of NPC in KCMH
Receive chemoradiation therapy as a primary treatment
Known pretreatment plasma EBV DNA level

Exclusion Criteria

Presence of metastasis
Received primary treatment other than chemoradiation
Previous chemoradiation therapy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Value of DCE-MRI in term of predicting chemoradiation sensitive nasopharyngeal carcinom 1 year DCE MRI parameters

Secondary Outcome Measures

Name	Time	Method
Value of DCE-MRI in term of predicting plasma EBV level in patient with nasopharyngeal carcinoma 1 year DCE MRI parameters